Morgan Creek Digital cryptocurrency hedge fund managing partner Mark Yusko is doubling down on a bullish prediction for Bitcoin (BTC) despite the recent market downturn.
Keep Reading →
November 17 - Hedge Funds, Insider Trading - Comments
NEW YORK (Reuters) - Firefly Value Partners on Thursday asked Gulfport Energy for a seat on its board and criticized the “half-measures” which the U.S.
Keep Reading →
November 21 - Hedge Funds, Insider Trading - Comments
David Einhorn has earned the attention of the investment community.
Keep Reading →
August 2 - Hedge Funds, Insider Trading - Comments
AQR Capital Management (AQR) has established an office in Frankfurt, Germany.
Keep Reading →
April 12 - Hedge Funds, Insider Trading - Comments
BOSTON (Reuters) - Activist hedge fund Starboard Value LP said on Friday it will no longer urge shareholders to oppose Bristol-Myers Squibb Co’s plans to buy Celgene Corp, even...
Keep Reading →
March 29 - Hedge Funds, Insider Trading - Comments
A Texas judge Tuesday dismissed a bondholder lawsuit against Neiman Marcus Group over the company’s transfer of its MyTheresa e-commerce business beyond the reach of bondholders...
Keep Reading →
March 19 - Hedge Funds, Insider Trading - Comments
Warren Buffett is possibly the financial world's most vocal critic of hedge funds.
Keep Reading →
March 12 - Hedge Funds, Insider Trading - Comments
Allergan shares rose Tuesday after renowned hedge fund manager David Tepper increased his pressure on the drugmaker, calling for the company to jump-start the business with new...
Keep Reading →
February 5 - Hedge Funds, Insider Trading - Comments
Numerous billionaire money managers, including the likes of Warren Buffett and Ken Fisher, absolutely love dividend stocks (check out a list of Ken Fisher's favorite dividend ...
Keep Reading →
December 7 - Dividend Stocks, Hedge Funds, News - Comments
Dividend yield is a very important metric that should be taken into account when picking a stock.
Keep Reading →
March 14 - Dividend Stocks, Hedge Funds, News - Comments
Shares of Corcept Therapeutics Inc.
Keep Reading →
February 5 - Market Movers, News - Comments
2017 has come to a close and it's been a wildly successful year for the stock market, as the S&P 500 jumped by 19% excluding dividends, the NASDAQ shot up by 28%, and the Dow ...
Keep Reading →
January 3 - Hedge Funds, News - Comments
The 10 biggest antidepressant drug companies in 2017 are committed to providing the safest and most cost-effective solution for consumers suffering from mental diseases worldwide...
Keep Reading →
December 14 - Lists, News - Comments
Opus Point Partners was founded by Michael S. Weiss and Dr. Lindsay A. Rosenwald in 2009. Prior to launching Opus Point Partners, Mr. Weiss and Dr.
Keep Reading →
August 25 - Hedge Funds, News - Comments
If someone is looking for convincing arguments about the wildly publicized doom of the hedge fund business, they don’t need to look far beyond the 2017 list of the highest paid...
Keep Reading →
May 23 - Hedge Fund Analysis, Hedge Funds, News - Comments
The markets are relatively quiet today as there are no major economic releases. The Dow Jones index is down 10 points, while the S&P 500 is 0.23% in the red.
Keep Reading →
March 20 - News - Comments
Founded in 2001, JANA Partners is led by billionaire Barry Rosenstein, along with co-portfolio managers David DiDomenico and Scott Ostfeld.
Keep Reading →
March 9 - Hedge Fund Analysis, Hedge Funds, News - Comments
Insider trading can be either legal or illegal.
Keep Reading →
March 2 - Insider Trading, News - Comments
Julian Robertson is an iconic hedge fund manager who started Tiger Management in 1980.
Keep Reading →
February 27 - Hedge Funds, News - Comments
Bristol-Myers Squibb Co (NYSE:BMY) will sell senior notes that are unsecured worth $1.5 billion.
Keep Reading →
February 23 - News, Stock Analysis - Comments
Reports indicate that the market for immuno-oncology drugs could grow to $25 billion in the next ten years.
Keep Reading →
February 21 - News, Stock Analysis - Comments
2016 was again a dismal year for the hedge fund industry, with a lot of hedge funds failing to beat the benchmark and some trailing it by a huge margin.
Keep Reading →
February 15 - Hedge Fund Analysis, Hedge Funds, News - Comments
Merck & Co., Inc. (NYSE:MRK) has agreed to share a portion of Keytruda sales with Bristol-Myers Squibb Co (NYSE:BMY) and Ono Pharmaceutical Co., Ltd.
Keep Reading →
January 24 - News, Stock Analysis - Comments
Bristol-Myers Squibb Co (NYSE:BMY) has opted to extend the research term of its discovery collaboration agreement with Five Prime Therapeutics Inc (NASDAQ:FPRX).
Keep Reading →
January 5 - News, Stock Analysis - Comments
After a strong 2015, health care stocks are leading the way lower in 2016. And it’s been an even uglier year for biotechnology company Gilead Sciences, Inc.
Keep Reading →
December 23 - News, Stock Analysis - Comments
There is a need for additional funding towards the development and clinical studies of AndexXa, a new compound that is a prospective antidote for Factor Xa inhibitors.
Keep Reading →
December 20 - News, Stock Analysis - Comments
Billionaire investors are successful for a reason. They do not funnel their money in ordinary places.
Keep Reading →
December 5 - Hedge Fund Analysis, Hedge Funds, News - Comments
David E. Shaw is an American computer scientist and investor who founded D.E. Shaw & Co., L.P. in 1988. The hedge fund manages a 13F portfolio of over $59.68 billion. David E.
Keep Reading →
December 5 - Hedge Fund Analysis, Hedge Funds, News - Comments
Renaissance Technologies is probably the best quant hedge fund in the market.
Keep Reading →
December 2 - Hedge Funds, News - Comments
Hedge fund legend Julian Robertson closed his hedge fund Tiger Management to outside investors way back in 2000 and has been using it as a vehicle to manage his own money since...
Keep Reading →
November 25 - Dividend Stocks, Hedge Fund Analysis, Hedge Funds, News - Comments
Tiger Management is a New York-based hedge fund founded in 1980 by legendary investor and billionaire Julian Robertson.
Keep Reading →
November 21 - ETF Trading, Hedge Fund Analysis, Hedge Funds, News - Comments
Bristol-Myers Squibb Co (NYSE:BMY) and Infinity Pharmaceuticals Inc.
Keep Reading →
November 10 - News, Stock Analysis - Comments
Twitter Inc (NYSE:TWTR): reported Q3 EPS of $0.13 which beat estimates by 4 cents. Revenue of $616 million was up 8.2% which beat estimates by $10.16 million.
Keep Reading →
October 27 - Earnings Report, Market Movers, News - Comments
Markets are trading on an optimistic note as all the major indices are in green zone.
Keep Reading →
October 10 - Market Movers, News - Comments
In this article we'll take a look at why VeriFone Systems Inc (NYSE:PAY), Dynavax Technologies Corporation (NASDAQ:DVAX), Gilead Sciences, Inc.
Keep Reading →
September 5 - Market Movers, News - Comments
Five Prime Therapeutics Inc (NASDAQ:FPRX) is a $1.25 billion biotech company that focuses on the discovery and development of protein therapeutics that block cancer and inflammatory...
Keep Reading →
August 31 - News, Stock Analysis - Comments
US stocks are trading slightly lower on Monday afternoon, as the major indexes retrieved from all-time highs reached on Friday, and a spike in energy stocks was not enough to ...
Keep Reading →
August 8 - Earnings Report, Market Movers, News - Comments
Bull sentiment dominated the markets during the first two trading sessions of the week, thanks to growing optimism about economic growth in the U.S after a strong jobs report, ...
Keep Reading →
July 13 - Market Movers, News - Comments
While there is no way to either deny or confirm the following statement, there is good reason to believe that hedge fund vehicles usually do not pay too much attention to insider...
Keep Reading →
June 17 - Insider Trading, News - Comments
Chicago billionaire Ken Griffin, the Founder and Chief Executive Officer of Citadel Advisors, was the highest-paid hedge fund manager in 2015, earning a stunning $1.7 billion ...
Keep Reading →
May 18 - Hedge Fund Analysis, Hedge Funds, News, Tech - Comments
It's the middle of earnings season and many investors are hungrily dissecting earnings reports and management commentary to get a better view on earnings outlooks for the future...
Keep Reading →
April 28 - Market Movers, News - Comments
Last week was marked by the S&P 500 entering into its eighth year of bull run amid an increase in oil prices and hopes of more stimulus from central banks.
Keep Reading →
March 15 - News - Comments
Hedge fund managers like David Einhorn, Dan Loeb, and Carl Icahn became billionaires by reaping large profits for their investors, which is why piggybacking their stock picks ...
Keep Reading →
March 9 - Hedge Fund Analysis, Hedge Funds, News - Comments
Large-cap stocks are generally less immune to sharp moves based on rumors than their mid and small-cap counterparts.
Keep Reading →
December 14 - Hedge Funds, News - Comments
Clifford Fox's Columbus Circle Investors is a multi-billion dollar investment management firm that has been primarily successful in picking small-cap and mid-cap stocks over ...
Keep Reading →
November 6 - Hedge Fund Analysis, Hedge Funds, News - Comments
It's Thursday and shareholders of BofI Holding, Inc.
Keep Reading →
October 15 - Market Movers, News - Comments
Zweig-DiMenna Partners is a US-based hedge fund managed by Joseph A. DiMenna, who co-founded the fund with Martin Zweig back in 1984.
Keep Reading →
May 19 - Hedge Funds, News - Comments
According to a Schedule 13D form filed yesterday with the Securities and Exchange Commission, Samuel Islay's Orbimed Advisors has slashed its stake in Intercept Pharmaceuticals...
Keep Reading →
March 26 - Hedge Funds, News - Comments
Bristol-Myers Squibb Co (NYSE:BMY) along with Ono Pharmaceutical launched a lawsuit against Merck & Co., Inc.
Keep Reading →
September 9 - News - Comments
Orbimed Advisors, led by Samuel Isaly, recently published its 13F filing with the U.S. Securities and Exchange Commission.
Keep Reading →
August 28 - Hedge Funds, News - Comments
